Targets for therapy in sarcomeric cardiomyopathies

To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Res
Autori principali: Tardiff, Jil C., Carrier, Lucie, Bers, Donald M., Poggesi, Corrado, Ferrantini, Cecilia, Coppini, Raffaele, Maier, Lars S., Ashrafian, Houman, Huke, Sabine, van der Velden, Jolanda
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
Invited Spotlight Reviews
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402369/
https://ncbi.nlm.nih.gov/pubmed/25634554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvv023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi